|
HS Code |
534494 |
| Iupac Name | octahydro-2-(phenylmethyl)-1H-pyrrolo[3,4-c]pyridine |
| Molecular Formula | C14H20N2 |
| Molecular Weight | 216.32 g/mol |
| Cas Number | 674794-53-5 |
| Smiles | c1ccc(cc1)CN2CCC3NC(C2)CC3 |
| Appearance | Solid (presumed, may vary with purity/source) |
| Solubility | Slightly soluble in water; soluble in organic solvents |
| Density | Predicted ~1.1 g/cm³ |
| Flash Point | Predicted >150°C |
| Structural Class | Bicyclic heterocycle (octahydropyrrolopyridine derivative) |
| Logp | Predicted ~2.3 |
| Synonyms | 2-Benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine |
As an accredited 1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a 25g amber glass bottle with a secure screw cap, labeled with chemical name, CAS number, and hazard warnings. |
| Container Loading (20′ FCL) | 20′ FCL container loaded with 1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)-; securely packaged in drums, suitable for bulk chemical transport. |
| Shipping | The chemical **1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)-** is shipped in tightly sealed containers under ambient conditions, with secondary containment to prevent leaks. It is labeled according to GHS standards, ensuring safe handling and compliance with transport regulations. Shipping documentation includes MSDS and hazard information to facilitate regulatory clearance. |
| Storage | 1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)- should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizers. Protect from moisture, heat, and direct sunlight. Properly label the storage area and container, and follow standard chemical storage protocols to ensure safety and stability of the compound. |
| Shelf Life | The shelf life of 1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)- is typically 2–3 years when stored properly, protected from light and moisture. |
|
Purity 98%: 1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)- with purity 98% is used in pharmaceutical intermediate synthesis, where it ensures consistent batch quality and high yield rates. Molecular weight 242.36 g/mol: 1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)- of molecular weight 242.36 g/mol is used in medicinal chemistry libraries, where it facilitates accurate compound characterization. Melting point 112°C: 1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)- with a melting point of 112°C is used in solid formulation processes, where it enhances temperature-controlled manufacturing. Stability temperature 50°C: 1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)- with a stability temperature of 50°C is used in long-term storage applications, where it maintains compound integrity under ambient conditions. Viscosity grade low: 1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)- with a low viscosity grade is used in solution-based screening assays, where it enables rapid dissolution and homogeneous mixing. Particle size <10 μm: 1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)- with particle size less than 10 μm is used in nanoparticle formulation research, where it improves dispersion and bioavailability. |
Competitive 1H-pyrrolo[3,4-c]pyridine, octahydro-2-(phenylmethyl)- prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Our team has spent years moving from benchtop ideas to larger reactors, scaling up and refining the process for manufacturing octahydro-2-(phenylmethyl)-1H-pyrrolo[3,4-c]pyridine. In our production environment, quality starts with how raw materials are sourced and treated. Through years of optimizing reaction conditions and purification, we have achieved a consistently high level of chemical purity and batch-to-batch reliability. This matters when your own downstream steps rely on clear, predictable input. We have spoken with customers who voice frustration over unexpected side products and low yield from alternate sources. That feedback led us to put greater emphasis on controlling moisture, reducing particulate residues, and verifying spectral signatures at multiple checkpoints. It is not just about measuring stats — it is about delivering a material you can trust for your most critical steps.
Most users see this molecule as a key intermediate for pharmaceutical synthesis, catalyst development, or specialty materials. Over the years, its structural elements — the fused bicyclic system, the benzyl group, and the saturated backbone — offer tools for building complexity without sacrificing stability. We have observed that researchers in medicinal chemistry use it as a backbone for developing novel CNS compounds, leveraging both the conformational rigidity and the synthetic accessibility. In our own manufacturing, every step is designed to keep the functional groups intact and prevent contamination that could create downstream issues, especially for those synthesizing sensitive APIs or fine chemicals.
Early on, our scale-up work faced challenges with controlling side reactions, especially during hydrogenation. We responded by investing in reactor technology that monitors reaction pressure and temperature profiles more closely, which cuts down on unwanted isomers. A customer once pointed out that batches from some suppliers contained higher levels of oligomeric byproducts. In response, we set up extra NMR checkpoints and single-peak HPLC assessments. Today, these routines ensure that our material meets the exacting standards required for the most demanding projects.
Octahydro-2-(phenylmethyl)-1H-pyrrolo[3,4-c]pyridine stands out for its unique architecture. The eight-membered ring affords ruggedness against hydrolysis, compared to related piperidine or azabicyclic compounds that may break down under acidic conditions. Medicinal chemistry teams point to the favorable profile in stability screens: in several reports we have received, prolonged storage in temperature-fluctuating environments led to no measurable decomposition. This sets it apart from less-stable analogs and simplifies storage logistics.
Structurally, the phenylmethyl (benzyl) moiety attached to the nitrogen allows for convenient functionalization, supporting both electrophilic and nucleophilic substitution reactions. This versatility streams directly from the way the molecule is built. Our chemists have explored both classical and photochemical methods for swapping the benzyl group, and the compound’s consistent performance has proven valuable when adapting to newer synthetic routes. This kind of stability has made the compound attractive for those seeking to build complexity without added process risk.
Comparing it to more common nitrogen heterocycles, octahydro-2-(phenylmethyl)-1H-pyrrolo[3,4-c]pyridine resists over-oxidation and maintains pharmacophoric integrity in a range of pH environments. In polymer precursor work, where other cyclic amines tend to yellow, lose mass, or leach, our molecule stays intact and color-stable — a frequently overlooked but important point in formulation work.
Over the years, customers have expressed concerns about variability in off-the-shelf supplies. Standardization has been one of our core focus areas. Analytical data carries little meaning without a comprehensive approach to batch tracking. With every lot, our QA staff rely not only on GC-MS and HPLC but also cross-reference spectral signatures and trace impurity levels. This helps us anticipate and avoid the common pitfalls of under-controlled production lots seen in lower-tier manufacturing.
In process chemistry, a subtle change in purity can require whole protocols to be revalidated or, worse, can shut down a scale-up campaign for weeks. The deeper we dove into customer feedback, the clearer it became that tiny lapses in process discipline — from filtration to drying parameters — can create ripple effects downstream. That’s why we invested in closed-system drying and high-surface area cartridge filtration. By minimizing airborne particulates, we enable others to scale up their chemistry without introducing unwanted variables.
Over time, we have found that sharing complete datasets, including full spectra and impurity profiles, helps researchers and process engineers develop better models for their own controls. Instead of handing over a certificate of analysis with only basic numbers, our team provides complete scan ranges. This is a habit that started after a client surfaced an outlier that basic metrics had missed. Collaboration on the specifics of the analytical profile improved both our understanding and our product.
Plenty of nitrogen heterocycles circle the market. The majority do not combine the ease of functional group tolerance with both saturated backbone and benzyl substitution. Many piperidine derivatives, for example, can fragment under harsh conditions, requiring tailored handling. Our octahydro-2-(phenylmethyl)-1H-pyrrolo[3,4-c]pyridine manages a robust architecture that withstands aggressive steps — catalytic hydrogenation, electrophilic aromatic substitution, and reductive amination among them — without falling apart.
Customers working with strained or unsaturated analogs often comment on increased reactivity to moisture and oxygen, both during shipping and long-term storage. We engineered our process to minimize the introduction of such points of failure, and this is reflected in the reduced need for strictly anhydrous or inertized shipping. Reports from several multi-kilo API teams indicate that this compound holds up better in transit and over extended shelf-life periods, which smooths operations and cuts costs on repackaging.
A few analogs serve as starting points for complexity, but tend to suffer from high background reactivity, which complicates selective derivatization. The moderate basicity and defined steric profile of our octahydro-2-(phenylmethyl) variant enables users to drive their reactions with greater specificity, according to those who have shared their route optimization stories with us.
The material stands out not only through its ruggedness but also through the investment we have made in in-process analytics and post-synthesis polishing. By sticking with column chromatography and multiple crystallization steps, and carefully tracking every post-reaction treatment, we consistently hit purity targets many other suppliers struggle to reach. Our approach grew out of direct conversations with process chemists who were tired of rework caused by inconsistent impurity profiles.
Pharmaceutical labs take advantage of the molecule’s fused ring and benzyl handle when exploring scaffolds for novel drug discovery or analog synthesis. One group shared with us how a clean supply allowed them to push forward in CNS-active fragment design, leveraging the backbone rigidity and metabolic stability. The ability to tolerate both electrophilic and nucleophilic chemistry without ring opening extends its use in multi-step synthesis programs. This aspect surfaced as especially important when moving from early discovery to scale-up, where intermediate breakdown could torpedo a campaign.
Fine chemical manufacturers, on the other hand, use octahydro-2-(phenylmethyl)-1H-pyrrolo[3,4-c]pyridine to construct custom ligands for catalysis or to anchor specialty polymers. Its predictable response to alkylation or acylation expands the pool of functional derivatives, reported to increase efficiency in catalyst support development by multiple groups we partner with.
A specialty materials company spoke with us about using this compound as a building block for high-durability polyamides. They highlighted the need for long-term shelf stability and predictable melt properties. They returned positive feedback on the absence of discoloration and minimal volatiles, which speaks to the cleanliness of our finishing process.
Delivering this molecule in kilogram-scale lots came with its own learning curve. There are real pitfalls in scaling up ring-closed intermediates. We set up our plant with flexible reactor volumes and modular filtration to keep batch cycles short and responsive to shifting order sizes. In the early years, limited reactor configurations forced us into inefficient campaign-style runs. That led to slow turnaround and variability in batch timing. Upgrading the plant paid off: today, whether the customer needs a few hundred grams or multi-kilo shipments, we can turn them around with tight lead times and without the bottlenecks we once faced.
Some manufacturing partners stressed the importance of reliable communication. Early on, delays happened when there was a mismatch in technical documentation or confusion about grade differences. This led us to overhaul our technical support routines — our chemists handle customer queries directly, rather than passing them off to non-technical staff. This way, troubleshooting or adaptation advice comes from the hands that actually make the molecule. One of our commercial biopharma partners commented that this approach saved them weeks in process adaptation, because real answers came from someone who had run reactions with the same compound.
Stability during transit creates challenges for many specialty amines, especially bulk shipments over hot or humid routes. Based on feedback from clients across several continents, we moved to upgraded barrier packaging and desiccant pouches as standard for quantities above laboratory scale. Lower-tier offerings in the market tend to use plain polyethylene. National and international researchers working in process development told us that even small moisture ingress can spark downstream color and purity issues. We solved this with laminated, gas-impermeable liners, which several long-haul customers say virtually eliminated parameter drift over weeks in shipping.
Making a fine chemical is about more than mixing and heating. Over years of back-and-forth with our own process engineers and customer R&D staff, it’s become clear that data integrity at every stage shapes the ultimate reliability of a compound. During a pilot project with a contract manufacturer, inconsistent hydrogen pressure led to an uptick in trace side products. As a result, we debugged the process, incorporated inline monitoring, and developed statistical controls to ensure purity specifications never drifted out of range.
Our folks in QC maintain archives of full analytical data for every lot, and we maintain full traceability from raw materials to final packaging. A few customers pressed for “beyond-certificate” transparency; giving them direct access to our raw data has helped them de-risk their own scale-up steps, since they can run baseline comparisons. This bidirectional trust improves outcomes for both sides of the relationship.
Accurate recordkeeping also allows us to spot patterns — learning from small spikes in impurity levels, or shifts in batch properties related to humidity on a given production day. We have stepped up our environmental controls in response to findings like these, and shared our lessons learned with our customer network, which has helped smaller labs set up their own internal QA.
As chemistries evolve and new downstream reactions are devised, material needs follow. Over the past decade, researchers have developed more complex, multi-functional small molecules. That has driven us to keep testing our process with new innovative transformations and alternative protecting group strategies. Recent projects used octahydro-2-(phenylmethyl)-1H-pyrrolo[3,4-c]pyridine as a pivotal intermediate for new chiral auxiliaries. Our process team worked directly with the developers, discussing conditions and sharing kinetic and impurity data — ensuring they had enough context through every optimization cycle.
Input from formulation specialists in the polymer and catalyst industries led us to make process tweaks that improved bulk handling characteristics, such as enhancing free-flowing consistency and reducing clumping. As a hands-on manufacturer, our flexibility means real-world challenges get shared all the way up from the workshop floor to R&D, and then built back into our production runs.
Our process improvement cycle draws from two-way communication with the field: plant operators flag changes in reaction exotherms, and customer technical teams alert us to subtle shifts in reactivity. It’s a loop that keeps us from falling behind broader advances in method development.
Large-scale chemical production always raises serious questions about safety and waste. We invested early in waste stream monitoring and solvent recovery systems, partly in response to industry trends and partly because process mishaps cost everyone more in the long run. Our team uses in-line sensors to track batch emissions, not just final product specs. During audits, visiting clients ask about energy and water usage, underscoring a growing expectation in the market: chemical manufacturers pay attention to their impact.
We experimented with alternative solvents and greener process aids, aiming to keep secondary impacts low while still reaching high yield. Newer rounds of optimization, influenced by best practices in responsible chemistry, helped us trim back on materials that contribute to problematic waste. In feedback cycles with formulation labs, reducing trace metal content and keeping out problem impurities made it easier for partners to qualify our intermediate in pharma pipelines focused on green chemistry goals.
This material represents years of cumulative experience, ongoing feedback, trial-and-error innovation, and a responsive approach to genuine market needs. Every technical challenge — from improving hydrogen uptake by slight stirrer modifications, to changing filtration temperatures after a spike in isolated moisture — taught us something about what customers really value. By keeping doors open for data-sharing, rapid feedback, and direct dialogue with industry professionals, we continue to shape not only our processes, but how our compound shows up in your workflow.
Octahydro-2-(phenylmethyl)-1H-pyrrolo[3,4-c]pyridine is more than a line in a catalog. Its properties, reliability, and track record in complex, high-stakes synthesis derive from hands-on experience, honest feedback, and a belief in open technical collaboration. Those values drive every batch.